U.S. Biomaterials Market Size & Outlook, 2023-2030
U.S. biomaterials market, 2018-2030 (US$M)
Related Markets
U.S. biomaterials market highlights
- The U.S. biomaterials market generated a revenue of USD 59,288.9 million in 2023 and is expected to reach USD 155,269.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 14.7% from 2024 to 2030.
- In terms of segment, metallic was the largest revenue generating product in 2023.
- Natural is the most lucrative product segment registering the fastest growth during the forecast period.
Biomaterials market data book summary
| Market revenue in 2023 | USD 59,288.9 million |
| Market revenue in 2030 | USD 155,269.2 million |
| Growth rate | 14.7% (CAGR from 2023 to 2030) |
| Largest segment | Metallic |
| Fastest growing segment | Natural |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polymers, Natural, Ceramics, Metallic |
| Key market players worldwide | Medtronic PLC, Evonik Industries AG, Carpenter Technology Corp, GNI Group Ltd, Invibio, Zimmer Biomet Holdings Inc, Basf SE, Covalon Technologies Ltd, Stryker Corp, Johnson & Johnson, Dentsply Sirona Inc, Corbion NV, CoorsTek |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.3% of the global biomaterials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biomaterials market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 23,699.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomaterials Market Scope
Biomaterials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. biomaterials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomaterials market will help companies and investors design strategic landscapes.
Metallic was the largest segment with a revenue share of 40.17% in 2023. Horizon Databook has segmented the U.S. biomaterials market based on polymers, natural, ceramics, metallic covering the revenue growth of each sub-segment from 2018 to 2030.
The large market share of the U.S. can be attributed to the presence of major market players involved in the manufacture and introduction of innovative solutions for reconstructive surgical procedures.
In addition, homegrown companies form strategic partnerships with each other as well as foreign established enterprises to enhance their presence in the implants market, which in turn is expected to boost market growth in the coming years.
Biomaterial implants play a very significant role in clinical practices, as they help recover from injuries and diseased conditions that affect the normal functioning of the body.
Reasons to subscribe to U.S. biomaterials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biomaterials market databook
-
Our clientele includes a mix of biomaterials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biomaterials market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biomaterials market size, by product, 2018-2030 (US$M)
U.S. Biomaterials Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
